Ironwood Investment Counsel LLC Takes $2.55 Million Position in Elevance Health, Inc. $ELV

Ironwood Investment Counsel LLC purchased a new position in shares of Elevance Health, Inc. (NYSE:ELV) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 7,891 shares of the company’s stock, valued at approximately $2,550,000.

A number of other institutional investors have also recently bought and sold shares of ELV. Vermillion & White Wealth Management Group LLC boosted its stake in shares of Elevance Health by 94.9% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company’s stock worth $30,000 after acquiring an additional 37 shares during the period. BOK Financial Private Wealth Inc. bought a new stake in Elevance Health in the 2nd quarter valued at $32,000. Physician Wealth Advisors Inc. lifted its holdings in Elevance Health by 331.6% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company’s stock valued at $26,000 after purchasing an additional 63 shares during the last quarter. Activest Wealth Management boosted its position in Elevance Health by 66.7% during the third quarter. Activest Wealth Management now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 34 shares during the period. Finally, Glass Jacobson Investment Advisors llc increased its holdings in shares of Elevance Health by 400.0% in the second quarter. Glass Jacobson Investment Advisors llc now owns 100 shares of the company’s stock valued at $39,000 after purchasing an additional 80 shares during the last quarter. Institutional investors and hedge funds own 89.24% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. TD Cowen restated a “buy” rating on shares of Elevance Health in a research note on Wednesday, November 26th. Weiss Ratings cut shares of Elevance Health from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday. Wall Street Zen upgraded shares of Elevance Health from a “hold” rating to a “buy” rating in a research report on Saturday, January 31st. Mizuho set a $413.00 price objective on Elevance Health in a report on Friday, January 9th. Finally, Royal Bank Of Canada lowered Elevance Health from an “outperform” rating to a “sector perform” rating and set a $358.00 target price on the stock. in a research note on Tuesday. Twelve analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $390.55.

Elevance Health Stock Up 2.0%

NYSE ELV opened at $338.98 on Friday. The company has a current ratio of 1.54, a quick ratio of 1.56 and a debt-to-equity ratio of 0.70. The company has a market cap of $75.33 billion, a price-to-earnings ratio of 13.49, a PEG ratio of 1.85 and a beta of 0.50. The company has a 50 day moving average of $352.03 and a 200-day moving average of $330.12. Elevance Health, Inc. has a 1-year low of $273.71 and a 1-year high of $458.75.

Elevance Health (NYSE:ELV) last issued its quarterly earnings results on Wednesday, January 28th. The company reported $3.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.10 by $0.23. The business had revenue of $49.31 billion for the quarter, compared to the consensus estimate of $49.52 billion. Elevance Health had a return on equity of 15.59% and a net margin of 2.84%.The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.84 earnings per share. Elevance Health has set its FY 2026 guidance at 25.500- EPS. On average, equities research analysts expect that Elevance Health, Inc. will post 33.96 earnings per share for the current fiscal year.

Elevance Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 25th. Investors of record on Tuesday, March 10th will be given a $1.72 dividend. The ex-dividend date is Tuesday, March 10th. This is an increase from Elevance Health’s previous quarterly dividend of $1.71. This represents a $6.88 dividend on an annualized basis and a dividend yield of 2.0%. Elevance Health’s dividend payout ratio (DPR) is 27.23%.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.